Journal of Cancer Research and Clinical Oncology | 2006(08) articles
- Editorial: what is the role of antiandrogen therapy in the treatment of prostate cancer?
- The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer
- Antiandrogen treatments in locally advanced prostate cancer: are they all the same?
- What implications do the tolerability profiles of antiandrogens and other commonly used prostate cancer treatments have on patient care?